Site icon OncologyTube

RECOURSE trial did performance status impact benefit from TAS-102 at Annual Meeting GI 2016

Alan P. Venook, MD of University of California San Francisco discusses RECOURSE trial and if performance status impact benefit from TAS-102 at ASCO GI 2016

Exit mobile version